<SEC-DOCUMENT>0000899923-25-000045.txt : 20250506
<SEC-HEADER>0000899923-25-000045.hdr.sgml : 20250506
<ACCEPTANCE-DATETIME>20250506160836
ACCESSION NUMBER:		0000899923-25-000045
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250506
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250506
DATE AS OF CHANGE:		20250506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		25917284

	BUSINESS ADDRESS:	
		STREET 1:		322 NORTH 2200 WEST
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84116
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		322 NORTH 2200 WEST
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84116
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mygn-20250506.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0f7feb1-3474-4d6b-8e7a-f251952d4654,g:678c3364-ecd1-474a-9e39-5979e1d21fb6,d:e9dcd269424443ffba09ab46f82702f5-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mygn-20250506</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0000899923</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mygn-20250506.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-06</xbrli:startDate><xbrli:endDate>2025-05-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie9dcd269424443ffba09ab46f82702f5_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">May 6, 2025</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-4">MYRIAD GENETICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.896%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">0-26642</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">87-0494517</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">322 North 2200 West</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">84116</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">801</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">584-3600</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12gTitle" id="f-18">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">MYGN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ie9dcd269424443ffba09ab46f82702f5_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2025, Myriad Genetics, Inc. ("Myriad" or the &#8220;Company&#8221;) announced its financial results for the three months ended March 31, 2025.&#160;&#160;The earnings release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cautionary Note Regarding Forward-Looking Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except for historical information contained in this Current Report on Form 8-K, including Exhibit 99.1, this Current Report on Form 8-K, including Exhibit 99.1, contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in Exhibit 99.1 to this Current Report on Form 8-K regarding these forward-looking statements.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ie9dcd269424443ffba09ab46f82702f5_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">Earnings release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">May 6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm"> for the three months ended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">March 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">25</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991mygn-xearningsrelease.htm">.</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibit(s) may contain hypertext links to information on our website or other parties&#8217; websites. The information on our website and other parties&#8217; websites is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Current Report on Form 8-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitation on Incorporation by Reference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with General Instruction B-2 of Form 8-K, the information set forth in Item 2.02 and in Exhibit 99.1 shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ie9dcd269424443ffba09ab46f82702f5_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.750%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: May 6, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Scott J. Leffler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scott J. Leffler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991mygn-xearningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i51d937d168064f75a9ffa906bf25c76c_4"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:175%">Exhibit 99.1</font></div><div style="text-align:center"><img alt="imagea.jpg" src="imagea.jpg" style="height:112px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Myriad Genetics Reports First Quarter 2025 Financial Results&#59;                          </font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Updates 2025 Financial Guidance</font></div><div style="text-align:center"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">Highlights</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%;padding-left:10.8pt">First</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%"> quarter </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">2025</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%"> revenue of $196 million declined by 3% year-over-year. Excluding headwinds</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:7.8pt;font-weight:700;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%"> of $16 million, revenue increased 5% year-over-year.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%;padding-left:10.8pt">First quarter 2025 Prenatal revenue grew 11% year-over-year, while Pharmacogenomics revenue declined by 20% year-over-year due to UnitedHealthcare (UNH) reduced coverage of GeneSight. MyRisk testing volume in the affected population grew 11% year-over-year. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%;padding-left:10.8pt">First quarter 2025 gross margin of 69% increased 40 basis points year-over-year, benefiting fr</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">om gr</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">eater laboratory efficiencies. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%;padding-left:10.8pt">First quarter 2025 GAAP net loss of $0.1 million, or $0.00 EPS, driven by $29 million tax benefit.</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">Adjusted EPS was $(0.03) in the first quarter 2025. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%;padding-left:10.8pt">Updated 2025 financial guidance with revenue in a range of $807 - $823 million and adjusted EPS range of $(0.02) - $0.02,</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:7.15pt;font-weight:700;line-height:150%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%"> </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%">reflecting first quarter 2025 results and the current business outlook.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">SALT LAKE CITY, May&#160;6, 2025 &#8211; </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Myriad Genetics, Inc. (NASDAQ&#58; MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its first quarter ended March&#160;31, 2025 and updated its previously issued financial guidance on business performance for the full-year 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;We had a challenging first quarter of 2025 with strength in our prenatal and oncology MyRisk tests offset by softness in GeneSight and unaffected hereditary cancer tests.  While we are actively working on initiatives to re-accelerate testing volumes, this will take time&#59; therefore we are lowering our 2025 financial guidance. We are taking immediate steps to reduce overall expenditures while prioritizing investment in new product development and programs intended to drive revenue growth,&#8221; said Sam Raha, President and CEO, of Myriad Genetics. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;As a new leadership team we are focused on unlocking Myriad Genetics' potential by implementing a compelling strategy, strengthening our organizational capabilities, and improving execution.&#8221;</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Attributable to UNH coverage of GeneSight, the divestiture of EndoPredict, and a one-time retroactive payor benefit in first quarter 2024. </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The company does not forecast GAAP EPS because it cannot predict certain elements that are included in the reported GAAP results.  Please see below under &#34;Financial Guidance&#34; for a full explanation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_7"></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:175%">Financial and Operational Highlights</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">Test </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">volumes of 385,000 in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">quarter of 2025 increased </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">1% year-over-year.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">The following table </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">summarizes year-over-year testing volume changes in the company's core product categories&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"><tr><td style="width:1.0%"></td><td style="width:44.877%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(in thousands)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2024</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:112%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Product volumes&#58;</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Hereditary cancer</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">73&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">71&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Tumor profiling</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(14)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Prenatal</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">173&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">172&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Pharmacogenomics</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">127&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">124&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Total</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">381&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Tumor Profiling decreased for the three months ended March 31, 2025 compared to the same period in the prior year due primarily to a decrease in testing volume for EndoPredict due to the sale of the company's international EndoPredict business in August 2024.</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">The following table summarizes year-over-year revenue changes in the company's core product categories&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"><tr><td style="width:1.0%"></td><td style="width:44.877%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(in millions)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:112%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Product revenues&#58;</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Hereditary cancer</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">86.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">88.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Tumor profiling</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">29.3</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">30.9</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(5)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Prenatal</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">49.3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">44.3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:8pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Pharmacogenomics</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">31.0</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">38.9</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(20)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Total</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">195.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">202.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">%</font></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1) Tumor Profiling decreased for the three months ended March 31, 2025 compared to the same period in the prior year due primarily to a decrease in testing volume for EndoPredict due to the sale of the company's international EndoPredict business in August 2024.</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">Operating expenses in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">quarter of 2025</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:150%"> </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">were $163.2 million, decreasing $2.3 million year-over-year. Adjusted operating expenses in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> quarter of 2025 increased $1.5 million year-over-year to $140.6 million, reflecting the company's commitment to disciplined cost management while maintaining investments in key strategic areas, such as research and development. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">Operating loss</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">quarter of 2025 was $29.0 million, an increase of $1.1 million year-over-year&#59; adjusted operating loss in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">quarter of 2025 was $5.5 million.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Cash Flow and Liquidity</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">First </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">quarter 2025 cash flow used in operations was $16.3 million&#59; adjusted cash flow used in operations in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">quarter of 2025 was $10.4 million, a decrease of $1.1 million year-over-year. Capital expenditures and capitalization of internal use software costs were $8.3 million in the </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">first</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> quarter 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">As of the end of the first quarter 2025, the company had cash and cash equivalents of $92 million and the ability to access an incremental $42 million of availability under its asset-based credit facility (ABL Facility). The continued availability and amount thereof under the ABL Facility is subject to maintaining compliance with the fixed charge coverage ratio and maintaining $20 million of cash in a controlled account with the administrator of the ABL Facility. </font></div><div style="text-align:justify"><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_10"></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Business Performance and Highlights</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Oncology</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The Oncology business delivered revenue of $77.7 million in the first quarter of 2025.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">First quarter 2025 hereditary cancer testing volume and revenue in Oncology grew 5% and 0% year-over-year, respectively, as MyRisk with RiskScore testing volume in the affected population grew 11% year-over-year. A year-over-year decrease in average revenue per hereditary cancer test in the first quarter 2025 was largely due to a difference in change in estimated revenue related to prior periods.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">First quarter 2025 Prolaris test revenue declined 2% year-over-year as Myriad Genetics continues to educate clinicians on how it believes the Prostate Cancer Guidelines from the National Comprehensive Cancer Network (NCCN</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:7.15pt;font-weight:400;line-height:150%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">) underscore the critical role of Myriad Genetics' portfolio of offerings across the patient&#8217;s prostate cancer journey. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:10.8pt">New clinical data highlighting the performance of the Precise MRD test was presented at the American Association for Cancer Research (AACR) conference in April 2025 and additional clinical data will be presented at the American Society of Clinical Oncology (ASCO) annual meeting in May 2025.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">Myriad continues to make progress and intends to commercially launch its first AI-driven prostate cancer test, in partnership with PATHOMIQ, by end of 2025. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Women&#8217;s Health</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The Women&#8217;s Health business delivered revenue of $87.2 million in the first quarter of 2025. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">Prenatal testing revenue in the first quarter of 2025 grew 11% year-over-year reflecting growth across both carrier screen and non-invasive prenatal testing. First quarter saw positive early adoption of the mid-fourth quarter 2024 launch of the Prequel Early Gestational Age test. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:11.4pt">First quarter 2025 hereditary cancer testing revenue for the unaffected population decreased 4% year-over-year on stable volume as the company continues to develop and deploy its electronic medical records (EMR) efforts and further expand its breast cancer risk assessment programs across its current and new provider base. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Pharmacogenomics</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">GeneSight test revenue was $31.0 million in the first quarter of 2025. As anticipated, first quarter this test revenue was impacted by UnitedHealthcare's decision to discontinue coverage of multi-gene panel pharmacogenetic testing, effective in the first quarter of 2025, as well as Myriad Genetics' actions to streamline the Pharmacogenomics organization.</font></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_13"></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Financial Guidance</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Myriad Genetics does not provide forward-looking guidance in accordance with accounting principles generally accepted in the United States (GAAP) for the measures on which it provides forward-looking non-GAAP guidance as the company is unable to provide a quantitative reconciliation of forward-looking non-GAAP measures to the most directly comparable forward-looking GAAP measure, without unreasonable effort, because of the inherent difficulty in accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliations that have not yet occurred, are dependent on various factors, are out of the company's control, or cannot be reasonably predicted. Such adjustments include, but are not limited to, real estate optimization and transformation initiatives, certain litigation charges and loss contingencies, costs related to acquisitions&#47;divestitures and the related amortization, impairment and related charges, depreciation, equity compensation, tax benefits, and other adjustments. For example, stock-based compensation may fluctuate based on the timing of employee stock transactions and unpredictable fluctuations in the company's stock price. Any associated estimate of these items and its impact on GAAP performance could vary materially.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Below is a table updating Myriad Genetics' full-year 2025 financial guidance*&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:4.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share amounts)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INITIAL       2025 Guidance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CURRENT     2025 Guidance</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2025 Comments</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$840 - $860</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$807 - $823</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lowered 2025 revenue range mid-point by $35 million reflecting an updated outlook for our pharmacogenomics business and hereditary cancer testing in our Women's Health business.</font></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gross Margin %</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">69.5% - 70.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">68.5% - 69.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margins expected to fluctuate in any quarter given product mix and pricing trends. </font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Adjusted Operating Expenses</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$575 - $595</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$555 - $565</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change reflects moderating planned expenditures for remainder of 2025.</font></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Adjusted EBITDA**</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25 - $35</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19 - $27</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Adjusted EPS***</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.07 - $0.11</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(0.02) - $0.02</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">*</font></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Assumes currency rates as of May 6, 2025.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">** </font></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Adjusted EBITDA is defined as Net Income (loss) plus income tax expense (benefit), total other income (expense), non-cash operating expenses, such as amortization of intangible assets, depreciation, impairment of long-lived assets, and share-based compensation expense, and one-time expenses such as expenses from real estate optimization initiatives, transformation initiatives, legal settlements, and divestitures and acquisitions.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">*** </font></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Full-year 2025 adjusted EPS is based on a 94 million share count.</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">These projections are forward-looking statements and are subject to the risks summarized in the safe harbor statement at the end of this press release.</font></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_16"></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Conference Call and Webcast</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">A conference call will be held today, Tuesday, May 6, 2025, at 4&#58;30 p.m. ET to discuss Myriad Genetics&#8217; financial results and business developments for the first quarter 2025. A live webcast of the conference call can be accessed on Myriad Genetics' Investor Relations website at </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;text-decoration:underline">investor.myriad.com</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">. To participate in the live conference call via telephone, please register at </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;text-decoration:underline">https&#58;&#47;&#47;register-conf.media-server.com&#47;register&#47;BI8e6e57340dc24b3c8f28f7d91cdac448</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. Following the conference call, an archived webcast of the call will be available at </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%;text-decoration:underline">investor.myriad.com</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_19"></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">About Myriad Genetics</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:150%;text-decoration:underline">www.myriad.com</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Myriad, the Myriad logo, BRACAnalysis, BRACAnalysis CDx, Colaris, MyRisk, Myriad myRisk, MyRisk Hereditary Cancer, myChoice, Tumor BRACAnalysis CDx, MyChoice CDx, Prequel, Prequel with Amplify, Amplify, Foresight, Foresight Universal Plus, Precise Tumor, Precise Oncology Solutions, Precise Liquid, Precise MRD, FirstGene, SneakPeek, SneakPeek Early Gender DNA Test, SneakPeek Snap, Urosuite, Mygenehistory, Health.Illuminated., RiskScore, Prolaris, and GeneSight are registered trademarks or trademarks of Myriad Genetics, Inc. All third-party marks&#8212;</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.47pt;font-weight:400;line-height:150%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> and </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.47pt;font-weight:400;line-height:150%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8212;are the property of their respective owners. &#169; 2025 Myriad Genetics, Inc. All rights reserved. </font></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_22"></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_25"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Product (Unaudited)</font></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_527"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:31.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.666%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.666%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WH</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ONC</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PGx</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WH</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ONC</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PGx</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hereditary Cancer</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tumor Profiling</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacogenomics</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.7&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.9&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.4&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.2&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Business Units&#58;</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">WH &#61; Women&#8217;s Health</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ONC &#61; Oncology</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">PGx &#61; Pharmacogenomics </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Product Categories&#58;</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Hereditary Cancer &#8211; MyRisk, BRACAnalysis, BRACAnalysis CDx</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Tumor Profiling &#8211; myChoice CDx, Prolaris, Precise Tumor, EndoPredict</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Prenatal &#8211; Foresight, Prequel, SneakPeek</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Pharmacogenomics &#8211; GeneSight</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_28"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_31"></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Operations (unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expense</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.0)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income tax</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.4)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense </font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.0)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and Diluted</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and Diluted</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_34"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets (unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</font></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.0&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, 92.2 and 91.3 shares outstanding at March&#160;31, 2025 and December&#160;31, 2024, respectively </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(756.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(756.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006.1&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027.6&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_37"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended<br>March 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash, cash equivalents, and restricted cash</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of the period</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of the period</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_40"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Safe Harbor Statement</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, including the company's updated full-year 2025 financial guidance, </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">statements regarding the company's prioritization of investment in new product development and programs intended to drive revenue growth, the company's intention to commercially launch its first AI-driven prostate cancer test, in partnership with PATHOMIQ, by the end of 2025, and the new leadership team&#8217;s focus on unlocking the company&#8217;s potential by implementing a compelling strategy, strengthening organizational capabilities, and improving execution. </font><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">These &#8220;forward-looking statements&#8221; are </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">management&#8217;s present expectations of future events as of the date hereof and are subject to a number of known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">These risks include, but are not limited to&#58; the risk that sales and profit margins of the company&#8217;s existing tests may decline&#59; the risk that the company may not be able to operate its business on a profitable basis&#59; risks related to the company&#8217;s ability to achieve certain revenue growth targets and generate sufficient revenue from its existing product portfolio or in launching and commercializing new tests to be profitable&#59; risks related to changes in governmental or private insurers&#8217; coverage and reimbursement levels for the company&#8217;s tests or the company&#8217;s ability to obtain reimbursement for its new tests at comparable levels to its existing tests, including with respect to UNH's coverage decisions to no longer provide coverage for certain multi-gene panel pharmacogenetic tests, including the company's GeneSight test&#59; risks related to increased competition and the development of new competing tests&#59; the risk that the company may be unable to develop or achieve commercial success for additional tests in a timely manner, or at all&#59; the risk that the company is not able to secure additional financing to fund its business, if needed, in a timely manner or on favorable terms, if it all&#59; the risk that the company may not successfully develop new markets or channels for its tests&#59; the risk that licenses to the technology underlying the company&#8217;s tests and any future tests are terminated or cannot be maintained on satisfactory terms&#59; risks related to delays or other problems with operating the company&#8217;s laboratory testing facilities&#59; risks related to public concern over genetic testing in general or the company&#8217;s tests in particular&#59; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems&#59; risks related to the company&#8217;s ability to obtain new corporate collaborations or licenses and acquire or develop new technologies or businesses on satisfactory terms, if at all&#59; risks related to the company&#8217;s ability to successfully integrate and derive benefits from any technologies or businesses that it licenses, acquires or develops&#59; risks related to the company&#8217;s projections or estimates about the potential market opportunity for the company&#8217;s current and future products&#59; the risk that the company or its licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying the company&#8217;s tests&#59; the risk of patent-infringement claims or challenges to the validity of the company&#8217;s patents&#59; risks related to changes in intellectual property laws covering the company&#8217;s tests, or patents or enforcement, in the United States and foreign countries&#59; risks related to security breaches, loss of data and other disruptions, including from cyberattacks and other cybersecurity incidents&#59; risks of new, changing and competitive technologies in the United States and internationally and that the company may not be able to keep pace with the rapid technology changes in its industry, or properly leverage new technologies to achieve or sustain competitive advantages in its products&#59; </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">the risk that the company may be unable to comply with financial or operating covenants under the company&#8217;s credit or lending agreements&#59; the risk that the company may not be able to maintain effective disclosure controls and procedures and internal control over financial reporting&#59; risks related to current and future investigations, claims or lawsuits, including derivative claims, product or professional liability claims, and risks related to the amount of the company's insurance coverage limits and scope of insurance coverage with respect thereto&#59; and other factors discussed under the heading &#8220;Risk Factors&#8221; contained in Part I, Item 1A of the company&#8217;s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on February 28, 2025, as well as any updates to those risk factors filed from time to time in the company&#8217;s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Myriad Genetics is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.309%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Investor Contact</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Matt Scalo</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(801) 584-3532</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">matt.scalo&#64;myriad.com</font></div></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Media Contact</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Kate Schraml&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(224) 875-4493  </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PR&#64;myriad.com</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_43"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Statement reg</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:700;line-height:150%">arding use of non-GAAP financial measures</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">In this press release, the company&#8217;s financial results and financial guidance are provided in accordance with accounting principles generally accepted in the United States (GAAP) and using certain non-GAAP financial measures. Management believes that presentation of operating results using non-GAAP financial measures provides useful supplemental information to investors and facilitates the analysis of the company&#8217;s core operating results and comparison of operating results across reporting periods. Management also uses non-GAAP financial measures to establish budgets and to manage the company&#8217;s business. A reconciliation of the GAAP financial results to non-GAAP financial results is included in the schedules below and a description of the adjustments made to the GAAP financial measures is included at the end of the schedules.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The company encourages investors to carefully consider its results under GAAP, as well as its supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand its business. Non-GAAP financial results are reported in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The company does not forecast GAAP operating expenses, net income (loss) or earnings per share because it cannot predict certain elements that are included in reported GAAP results.  Please see above under &#8220;Financial Guidance&#8221; for a full explanation.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="i51d937d168064f75a9ffa906bf25c76c_46"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_49"></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Financial Measures</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">for the Three Months Ended March 31, 2025 and 2024</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(unaudited data in millions, except per share amounts)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.783%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Gross Margin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Gross Profit</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition - amortization of intangible assets</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Equity compensation</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Other adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Gross Profit</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Gross Margin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents recurring amortization charges resulting from the acquisition of intangible assets.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the non-cash equity-based compensation provided to Myriad Genetics employees.</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other one-time non-recurring expenses for the three months ended March 31, 2025 and March&#160;31, 2024. </font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Operating Expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition - amortization of intangible assets</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate optimization</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformation initiatives</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Operating Expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.1&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents recurring amortization charges resulting from the acquisition of intangible assets.</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the non-cash equity-based compensation provided to Myriad Genetics employees and directors.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to real estate initiatives. For the three months ended March 31, 2025, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South San Francisco, California, while maintaining our current laboratories in those locations and testing and set-up costs for equipment in our new facilities. For the three months ended March 31, 2024, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South Francisco, California, while maintaining our current laboratories in those locations, costs associated with the voluntary termination of a lease, testing and set-up costs for equipment in our new facilities, and impairment in connection with the ceased use of one of our facilities.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to transformation initiatives including consulting and professional fees for the three months ended March 31, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to one-time legal expenses, net of reimbursement for the three months ended March 31, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other one-time non-recurring expenses. For the three months ended March 31, 2025, consists primarily of severance related costs. For the three months ended March 31, 2024, primarily includes a gain recognized on acquisition, changes in the fair value of contingent consideration related to acquisitions from prior years, the reclassifications of cumulative translation adjustments to income upon liquidation of an investment in a foreign entity, and costs incurred in connection with executive personnel changes.</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.783%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Operating Loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating Loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition - amortization of intangible assets</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate optimization</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformation initiatives</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Operating Loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents recurring amortization charges resulting from the acquisition of intangible assets.</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the non-cash equity-based compensation provided to Myriad Genetics employees and directors.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to real estate initiatives. For the three months ended March 31, 2025, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South San Francisco, California, while maintaining our current laboratories in those locations and testing and set-up costs for equipment in our new facilities. For the three months ended March 31, 2024, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South Francisco, California, while maintaining our current laboratories in those locations, costs associated with the voluntary termination of a lease, testing and set-up costs for equipment in our new facilities, and impairment in connection with the ceased use of one of our facilities.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to transformation initiatives including consulting and professional fees for the three months ended March 31, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to one-time legal expenses, net of reimbursement for the three months ended March 31, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other one-time non-recurring expenses. For the three months ended March 31, 2025, consists primarily of severance related costs. For the three months ended March 31, 2024, primarily includes a gain recognized on acquisition, changes in the fair value of contingent consideration related to acquisitions from prior years, the reclassifications of cumulative translation adjustments to income upon liquidation of an investment in a foreign entity, and costs incurred in connection with executive personnel changes.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.783%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Net Loss </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition - amortization of intangible assets</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate optimization</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformation initiatives</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax benefit</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Net Loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and Diluted</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Loss Per Share</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and Diluted</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">To determine Adjusted Earnings (Loss) Per Share, or adjusted EPS.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents recurring amortization charges resulting from the acquisition of intangible assets.</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the non-cash equity-based compensation provided to Myriad Genetics employees and directors.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to real estate initiatives. For the three months ended March 31, 2025, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South San Francisco, California, while maintaining our current laboratories in those locations and testing and set-up costs for equipment in our new facilities. For the three months ended March 31, 2024, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South Francisco, California, while maintaining our current laboratories in those locations, costs associated with the voluntary termination of a lease, testing and set-up costs for equipment in our new facilities, and impairment in connection with the ceased use of one of our facilities.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to transformation initiatives including consulting and professional fees for the three months ended March 31, 2024.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to one-time legal expenses, net of reimbursement for the three months ended March 31, 2024.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other one-time non-recurring expenses. For the three months ended March 31, 2025, consists primarily of severance related costs. For the three months ended March 31, 2024, primarily includes a gain recognized on acquisition, changes in the fair value of contingent consideration related to acquisitions from prior years, the reclassifications of cumulative translation adjustments to income upon liquidation of an investment in a foreign entity, and costs incurred in connection with executive personnel changes.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the release of unrecognized tax benefits and the recognition of valuation allowances for the three months ended March 31, 2025. The unrecognized tax benefits released were primarily related to tax years under Joint Committee on Taxation review, which upon conclusion of the review were remeasured or released.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax expense or benefit due to non-GAAP adjustments, differences between stock compensation recorded for book purposes as compared to the allowable tax deductions, and valuation allowance recognized against federal and state deferred tax assets in the United States. As of March&#160;31, 2025, a valuation allowance of $67.0 million was not recognized for non-GAAP purposes given our historical and forecasted positive earnings performance. As of March&#160;31, 2024, a valuation allowance of $57.0 million was not recognized for non-GAAP purposes given the company's historical and forecasted positive earnings performance.</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition - amortization of intangible assets</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate optimization</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformation initiatives</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of interest income</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax benefits</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents recurring amortization charges resulting from the acquisition of intangible assets.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation expense excludes depreciation included in real estate optimization of $0.5 million for the three months ended March 31, 2024. No depreciation expense was included in real estate optimization for the three months ended March 31, 2025.         </font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the non-cash equity-based compensation provided to Myriad Genetics employees and directors.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to real estate initiatives. For the three months ended March 31, 2025, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South San Francisco, California, while maintaining our current laboratories in those locations and testing and set-up costs for equipment in our new facilities. For the three months ended March 31, 2024, additional rent as a result of the build-out of our new laboratories in Salt Lake City, Utah and South Francisco, California, while maintaining our current laboratories in those locations, costs associated with the voluntary termination of a lease, testing and set-up costs for equipment in our new facilities, and impairment in connection with the ceased use of one of our facilities.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to transformation initiatives including consulting and professional fees for the three months ended March 31, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs related to one-time legal expenses, net of reimbursement for the three months ended March 31, 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derived from interest expense and interest income from the Condensed Consolidated Statements of Operations.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other one-time non-recurring expenses. For purposes of adjusted EBITDA, this includes Other adjustments described in Adjusted Net Loss above as well as the amounts reported as Other income (expense) in the Condensed Consolidated Statement of Operations.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the release of unrecognized tax benefits and the recognition of valuation allowances for the three months ended March 31, 2025. The unrecognized tax benefits released were primarily related to tax years under Joint Committee on Taxation review, which upon conclusion of the review were remeasured or released.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derived from income tax (benefit) from the Condensed Consolidated Statement of Operations, net of the adjustment for unrecognized tax benefits described above.  </font></div></td></tr></table></div><div><font><br></font></div><div id="i51d937d168064f75a9ffa906bf25c76c_52"></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Free Cash Flow Reconciliation</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:120%">for the Three Months Ended March 31, 2025 and 2024</font></div><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(unaudited data in millions)</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted free cash flow</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate optimization</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformation initiatives</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating cash flow</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of internal-use software costs </font><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted free cash flow</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The cash flow effect of real estate optimizations, excluding non-cash items such as accelerated depreciation.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transformation initiatives includes the cash paid for those costs in the related periods.  </font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The cash flow effect of severance and executive personnel changes in the related periods.  </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derived from the Condensed Consolidated Statements of Cash Flows. </font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'ITC Franklin Gothic LT Pro Bk',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mygn-20250506.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0f7feb1-3474-4d6b-8e7a-f251952d4654,g:678c3364-ecd1-474a-9e39-5979e1d21fb6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mygn="http://myriad.com/20250506" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://myriad.com/20250506">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20250506_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20250506_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20250506_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://myriad.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mygn-20250506_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0f7feb1-3474-4d6b-8e7a-f251952d4654,g:678c3364-ecd1-474a-9e39-5979e1d21fb6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20250506.xsd#Cover"/>
  <link:definitionLink xlink:role="http://myriad.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_559ba456-498f-4287-840a-e9ac0adc48be_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:to="loc_dei_AddressTypeDomain_559ba456-498f-4287-840a-e9ac0adc48be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e2fff404-346a-4de5-9ba7-d825dea92df1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:to="loc_dei_AddressTypeDomain_e2fff404-346a-4de5-9ba7-d825dea92df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e307dca8-20ad-4168-9d8d-36ecc89b2991" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_DocumentType_e307dca8-20ad-4168-9d8d-36ecc89b2991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_adfa1a8b-fb54-40d7-8015-0d78a4614107" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_DocumentPeriodEndDate_adfa1a8b-fb54-40d7-8015-0d78a4614107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_88586b09-8910-49c0-9589-6bb72a6a1409" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityRegistrantName_88586b09-8910-49c0-9589-6bb72a6a1409" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8f004b6e-b51c-4549-8a35-2c7020833bac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityCentralIndexKey_8f004b6e-b51c-4549-8a35-2c7020833bac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b94d07c7-5565-4261-aa82-3833c6147a41" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_AmendmentFlag_b94d07c7-5565-4261-aa82-3833c6147a41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e7f7933f-de48-4e88-9fd6-eb319fe1339d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e7f7933f-de48-4e88-9fd6-eb319fe1339d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_89fe84c2-27e5-476c-9e61-f8daf881b53e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityFileNumber_89fe84c2-27e5-476c-9e61-f8daf881b53e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bae0c7cb-64a2-40c1-a46d-b095d55d82a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityTaxIdentificationNumber_bae0c7cb-64a2-40c1-a46d-b095d55d82a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9da56b30-d144-4214-8128-4c7577db2d08" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressAddressLine1_9da56b30-d144-4214-8128-4c7577db2d08" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_84c7d3c5-06e0-4e0d-9781-f75ca9f9473c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressCityOrTown_84c7d3c5-06e0-4e0d-9781-f75ca9f9473c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fb01797f-e1a9-41da-8ad4-444db33d1e89" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressStateOrProvince_fb01797f-e1a9-41da-8ad4-444db33d1e89" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_43b22f8d-fdcb-4c9a-a5a9-9e4752a4d55c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressPostalZipCode_43b22f8d-fdcb-4c9a-a5a9-9e4752a4d55c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_72648d46-7d3d-4249-8bdd-22824a3f4ba4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_CityAreaCode_72648d46-7d3d-4249-8bdd-22824a3f4ba4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_650aabb5-63c4-40d7-ae6c-0bbd624e602f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_LocalPhoneNumber_650aabb5-63c4-40d7-ae6c-0bbd624e602f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_fecd9049-201b-4504-b11e-3b4721a1e039" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_WrittenCommunications_fecd9049-201b-4504-b11e-3b4721a1e039" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_359152b7-6205-4de2-a6aa-44ee3fc0397e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_SolicitingMaterial_359152b7-6205-4de2-a6aa-44ee3fc0397e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_fb1de2b2-3692-4c95-8ed9-fbd26b773397" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_PreCommencementTenderOffer_fb1de2b2-3692-4c95-8ed9-fbd26b773397" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_60b93f93-6e67-4d9c-9058-79f4fa0230c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_60b93f93-6e67-4d9c-9058-79f4fa0230c0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_fcb82f96-eb81-4cc3-8289-6e71698e15ee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_Security12gTitle_fcb82f96-eb81-4cc3-8289-6e71698e15ee" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3e232651-d205-45f3-b7d9-e25877506213" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_TradingSymbol_3e232651-d205-45f3-b7d9-e25877506213" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a0e3f21e-3008-4f3b-bdea-56154373a051" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_SecurityExchangeName_a0e3f21e-3008-4f3b-bdea-56154373a051" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_089782d0-c17a-41ed-85f9-44ede65e6524" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityEmergingGrowthCompany_089782d0-c17a-41ed-85f9-44ede65e6524" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mygn-20250506_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0f7feb1-3474-4d6b-8e7a-f251952d4654,g:678c3364-ecd1-474a-9e39-5979e1d21fb6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentPeriodEndDate_fe8be4e4-1777-4694-ba7f-4c64449799f3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_aafb2c50-7be3-4977-9850-1c39034843f9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_32c0ad47-0831-4c8d-8c21-1156bbacb527_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_8f4fc71d-ae57-420f-b059-0501aecbd657_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_976528fc-4fe5-4dd3-9a06-bb87de89effe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_27dd5a8d-4587-442b-a410-1c2eccb26642_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_69624b67-628b-4b46-9426-4517f4b4a094_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c3bb334e-aef2-4488-8548-2a1c0e8ee340_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7004be86-f4fb-402e-9cd1-64ecb91dda99_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_230a2177-3d2c-4468-957e-465cd6b6f697_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_d5c537b2-992e-44b2-982d-48c069f735fd_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_15991f8d-3043-42d3-8808-523926c7f001_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e34c336b-4739-4e2e-8fa7-095edc300488_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_71ae11b2-d6b6-4e52-bfba-ecf1b830156b_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_33862dfb-7c1a-4828-bfaf-fe04ce5a5d9a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fb7de4a0-08a3-4579-9aa9-1258fc152d0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c0ef03eb-e11e-44d4-bc0c-33c1196294a6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7040d8d9-fdf7-4e99-8daf-7f0112de6c92_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_73d71cba-799f-49c6-8fef-2e65bdcfb2f7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1db4ce65-da3b-4373-9a0c-921a5acf70d0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_436efc2e-5ef1-4051-a52c-f34894da0426_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9a902ba7-ed00-4441-b965-7ad9d83b7f10_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_714560a5-5aa8-48ac-9174-4f180b791170_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c40dc5ac-474a-4e8f-bc88-74e067c222ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12gTitle_fe9f6285-34e7-4267-9503-a8e90932110f_terseLabel_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:label id="lab_dei_Security12gTitle_label_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12gTitle" xlink:to="lab_dei_Security12gTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_92a3c34c-5230-411a-9a0c-783aafc33037_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mygn-20250506_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0f7feb1-3474-4d6b-8e7a-f251952d4654,g:678c3364-ecd1-474a-9e39-5979e1d21fb6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20250506.xsd#Cover"/>
  <link:presentationLink xlink:role="http://myriad.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e5b2de5d-808c-416d-a1ef-c8eb1d8903f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e5b2de5d-808c-416d-a1ef-c8eb1d8903f0" xlink:to="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e2fff404-346a-4de5-9ba7-d825dea92df1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_559ba456-498f-4287-840a-e9ac0adc48be" xlink:to="loc_dei_AddressTypeDomain_e2fff404-346a-4de5-9ba7-d825dea92df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_012c3922-d1ad-476a-a516-b76284439cc7" xlink:to="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e307dca8-20ad-4168-9d8d-36ecc89b2991" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_DocumentType_e307dca8-20ad-4168-9d8d-36ecc89b2991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_adfa1a8b-fb54-40d7-8015-0d78a4614107" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_DocumentPeriodEndDate_adfa1a8b-fb54-40d7-8015-0d78a4614107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_88586b09-8910-49c0-9589-6bb72a6a1409" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityRegistrantName_88586b09-8910-49c0-9589-6bb72a6a1409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8f004b6e-b51c-4549-8a35-2c7020833bac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityCentralIndexKey_8f004b6e-b51c-4549-8a35-2c7020833bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b94d07c7-5565-4261-aa82-3833c6147a41" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_AmendmentFlag_b94d07c7-5565-4261-aa82-3833c6147a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e7f7933f-de48-4e88-9fd6-eb319fe1339d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e7f7933f-de48-4e88-9fd6-eb319fe1339d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_89fe84c2-27e5-476c-9e61-f8daf881b53e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityFileNumber_89fe84c2-27e5-476c-9e61-f8daf881b53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bae0c7cb-64a2-40c1-a46d-b095d55d82a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityTaxIdentificationNumber_bae0c7cb-64a2-40c1-a46d-b095d55d82a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9da56b30-d144-4214-8128-4c7577db2d08" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressAddressLine1_9da56b30-d144-4214-8128-4c7577db2d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_84c7d3c5-06e0-4e0d-9781-f75ca9f9473c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressCityOrTown_84c7d3c5-06e0-4e0d-9781-f75ca9f9473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fb01797f-e1a9-41da-8ad4-444db33d1e89" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressStateOrProvince_fb01797f-e1a9-41da-8ad4-444db33d1e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_43b22f8d-fdcb-4c9a-a5a9-9e4752a4d55c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityAddressPostalZipCode_43b22f8d-fdcb-4c9a-a5a9-9e4752a4d55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_72648d46-7d3d-4249-8bdd-22824a3f4ba4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_CityAreaCode_72648d46-7d3d-4249-8bdd-22824a3f4ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_650aabb5-63c4-40d7-ae6c-0bbd624e602f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_LocalPhoneNumber_650aabb5-63c4-40d7-ae6c-0bbd624e602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_fecd9049-201b-4504-b11e-3b4721a1e039" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_WrittenCommunications_fecd9049-201b-4504-b11e-3b4721a1e039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_359152b7-6205-4de2-a6aa-44ee3fc0397e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_SolicitingMaterial_359152b7-6205-4de2-a6aa-44ee3fc0397e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_fb1de2b2-3692-4c95-8ed9-fbd26b773397" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_PreCommencementTenderOffer_fb1de2b2-3692-4c95-8ed9-fbd26b773397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_60b93f93-6e67-4d9c-9058-79f4fa0230c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_60b93f93-6e67-4d9c-9058-79f4fa0230c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_fcb82f96-eb81-4cc3-8289-6e71698e15ee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_Security12gTitle_fcb82f96-eb81-4cc3-8289-6e71698e15ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3e232651-d205-45f3-b7d9-e25877506213" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_TradingSymbol_3e232651-d205-45f3-b7d9-e25877506213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a0e3f21e-3008-4f3b-bdea-56154373a051" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_SecurityExchangeName_a0e3f21e-3008-4f3b-bdea-56154373a051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_089782d0-c17a-41ed-85f9-44ede65e6524" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a1b6c40b-1d6d-4453-bdc7-91091cddfa6c" xlink:to="loc_dei_EntityEmergingGrowthCompany_089782d0-c17a-41ed-85f9-44ede65e6524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>imagea.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imagea.jpg
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M0@@AA) ?=Y(J-!S,7B8]M_VA=/CBOTGG+;\KG;;^GK[_#7W_WV7[U:EFS,$
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MH0&L7;])/JK7S,84??8&/+PX6K3L* </'K%\U14:W!_NI; P7R9-FFE]]X(
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M^WUZLX2&V'G"G%BY<IV,'3]-^@X89LN6NG;O+SW5@!TZ?)S,F;M$#AP\7&J
M/WWZ3*9.GV-B$*Y;S+5NW?O)Z=-GXZYM3_@S"!<(TCEO_E(9/G*"I/?[6+KU
MZ&\)6Y@._GB43)TV1S9NVAKR.L$\J_CZOWGKMFTO.G_!4EFP:)DL7+1<KU%-
M^CIGWA(Y=/A87!M@I!\]=E+S+Y&A(\:JH3[8=F[HWG. #!@X7*9,G2G;MN^T
MMAKE]*DBPO7DY3V5@P>/6CM&C)XH?:RO W1L!T@/_9T8.'BD3)XR2S[;\$5I
M3!=0WA@"&/K;M^^6V7H^YBU<)HL7?R(S9RV0-AVZN^5G\.32N3YBY$19O/03
M&PO4;>,1I/D+ELDB/>[R%2^&NKH>/7HL*U>MM_.2> S2/#T.PN]-O3ZK.A^>
M<#]R<_-DW[Y#6LY2'8OQ>MZ'Z)CWLW''/!O\\1B=4W-M2V#\!GB<L!$>#_?>
M_AM\#I$*@O7 (:/,&PH[U#1MV5Y:MNID6PX/T'%&'RY=OF+Y5Z_YS+Q >FO"
M/'.$ZR"$$$((J1EO0#!(CY,-(GD/)3JE@41[?%NBB4LGTM^7:+=O2&1I3_-H
MJ Q_(^9N_J*RY7J>_/2X(!9#G-"@:<Q5^:EQUV7F*>QF\'H\&L+DY#RV)]78
M$C)LE&'GAB9ZXWSRE-_FLFPEX1O0O?L.2K.6'<RK(+8$HXVT:M-%CAT_&>2*
M/^9YJ%AH:"MUL*VE&F:Y>2[VQ>O@90L-&#^?RAH!^KU^5EA89$;6_?N/).-J
MIFW?>?3("3E\Z)@<.7)<CJN1=^K46;EX\8H:"=GV%!WS(#^_P.(]=.K2N]2C
MP8L$7FBHS*,AS)IU&ZP,?SP2GOC"$/MB\[8@U\L!2V=<D-/P_'C]0D/XW $\
M45^H!GF;=MWLNL%3<23L! -/!;S6T7D$ :U9BXXR;L(T/6>7U6A;9D(*XI_4
MT_QMVG55P_V$E9DX'W#%>(Z?."6#AHR4IBW:FR"(8^'Y@6"MJ M!.B$PUFO0
MRG8>Z:Z&Z,Z=>R6J!C; 4_?R/!-.GSTGS5+:6ULA4$%,PBO._X]J-Y7YVD?/
MG3OW9,K46=*B54?]7NM"TKF%<X/\\(A"WR!*C1PS26[=NFW'5658)[8)XS1\
MQ'C[34*Y*!/M<_UT?:Y3O[G4;>AB*W3NVD<V;=XN1<6Q)^_A\@"\<,:,FZI]
M:J;]:R4-M-WH*W[K,+\PUR$V-&SL!#74Z\<#[[&,S'M\)6Z!"6^.CEW2K7U^
M[-R8N(2VHR^X;AV)YSD>/4VEG#AYQD2 9BWT]UG+PECX<^Y3G7HZSVSY1ZI>
M_WU,?"DH\-OZNM\9EX+W]HW(H<-'I4O7=(N-@X1VVCS25S^7/ZS3S%ZQA ["
MPJ0I,RW/![6;R*+%?FY4WA]"""&$D,IX@X0&1S12*)%/^DE)]V^9L! .!FE+
M*1"_8?P'4IR+W2% 53=#^+Y$1AS.D5K#$)OA>EFA8?15^:_3,F7K=1ALE9?W
M*H0&@*=ON-'T-\QVTZSIH[K-]+L5Y98?OA''*YYHXH;8/<'V3\%;6T3VVW?B
MU^._")5Y-$ LF31EEKD'ORY>OM#@Y@421@,4%!;8UJ$[=^[1\[52QHR?*GWZ
M#94.:>G2.K6K-%<CM:F>DZ9Z3K#=9',U-%NF=)16K=.D=9LNFJ^'=.W65_H-
M&";]!XZ0EJW2[#R&VU]3H6'9\E5F+(6%!@A/S=58VK-G?Y#KY8#8(C"JPEXZ
M2)B?;X+0 *Y=SY0AP\:J =92ZNMU L,>L1;@>M^V?0_IF-9;6K=%C L($! ;
M4DT80*!.OR2EOAIV+5/39-=N-YXHV\V+>+!LZ=-5&^Q)\T=J8$)$K-\0]:6H
M\=I1VNGYQY/GU'9=30RJ6U\-3C6688A#&,*U[<Z[*]^+#389E9.GSTHC;?<'
MM9MJ?]1XU^,;-X$'2SNIK=?!XB5N"=:5C.LZOT::X8FY@3D% _2CP-CU\\6)
ME*E26XW1CX>.J9:'DA<B(+)M^'RSI.J\QO$0<#"^=75L8:BW;=]=^]I3VK3O
M:G4Y<43'0L>X0:,V,F?N8GD<;!&;^%L%H6&47ML_^*"Q+0FS\V+"@1/04%XC
MG6<0AA"S 88V^N@%)&^(HTV)0L.-&]G2KD,/^>&'374\U%C7\:@#P4?'L+$F
M>$RT:-593I\^'QP1W[;R*"@HE+7K-DHK_=W!6#1LC&UJ<5XA6K2W&"HX[VT[
M=-??!0A%$'ZTO3I6$"1FS)QG8AC >??SUX_+F;/GI:,>CW/74/N._N$W#EXX
M,V8OM%UGIDR;8[\IS76>??!1,[L.V^@<MG\?=/S@">&HNC^$$$(((17Q1@D-
MN*V)Z U39,=LB?9^5TK2WRT5&9Q'@Z:>?RK1P7\CQ5>/!%X-E3]5P_=%>L-;
M;\-=V[ZRC,B -.*J?'=AMEQZ!#?HRF^N<'/W*H0&[%Z0TKJS/07V1AF$!MPD
M#QPRLO3&.Q%_PPD/ CP]=%X1,"S;6QFXV<;32[@<)XN*A 88)_4:M)8Y\Q>_
MUEO6ER\TQ 0&&#YPJ1\W?JJD=>ICQ@*>$IN!HV,! POUXKS:*YZVJB'IDOZM
MR3T];6WY<;YL7-4("+<="9_71&B8OW"9'H.GO;XL9QRGI':2PX>/!;F2"<;$
M79]'CY\TL03UA?OP)@@-X-[=N])/VP&##P%,843"L!\U9I+LW+5/+EVZ8L+1
MN?,79>,7VZS-V#(6_4$?_'F$8+1QT^92<2%L!'H@NBU=_JGFU_XW3+7Z8/PC
M8.;B)9_86OHK&1ER[=HUN:CU[MBY1T:-GF2" ^K"O&G0I+4L7[':3[O2>GQ=
M:.O(T1-E\,>C9>B(<9+>=ZC.Q0YJ(#LOAQ4KUYA8,&#0"/L;<ZE>PY;2METW
M_=V8(%.GSY/Q$V:8)PT,=W?>VFL;L(2KI2W#J.PWQ+7#M6?]9YOL.L!\QF\"
MQ(#4MIUEGAJ]6$:!F %H+\9X]Y[],G'23*L+X@#Z"K%C_ORE6E_9W_KBXHC,
M6[#8C.N>/0=(CY[]I7.W/M(\I:/VU0D-3?2<=.C40[KW<DM!>O3HKPFO+G7K
MUL^NH\-'XJ^!>_?NV3(.!%R%5]8P_3V%6 C!#&7#\,>U<_I,]80&Q/7 .<,\
MP;%8SH;?Y]9:QIPY"W4LCLB5*SCOU^7RI0S9?^"(S)Z[2%KK6&$,<!Q$L F3
M9IAWE(UO*"9#?GZAC!P[V3P3\&\%A!<LAX#'5&YNKL7%0(P*_$8A=L/APT=M
MJ0KF'LK&6.'<+%VF_WX9E?>'$$(((:0RWCBA >&\(J>V2*3_7XGT^M-XH4$3
M@D0B1?8O=R8,C#P],+C7"H$;,.2(R,V\0OFSQ3>EUB@?GR%AUXD15^3?UMR6
MG *KW8ZNB)<M-/B;QMPG3V2PWN#"  @;9KCQ;M>Q9[G&,8[T3Q&O7\_4?-@F
M,S L]:;6K\??L=,%1O-UO2@5"0UXH@KC MX9KY.7)31@^,)C>%[+&3]ANC15
M0P1//S$>MC2A*<8^,'J"\?'G!*_>V\3B:)0F_-V^]+NX?$'[:RHTX&FFG:.@
M#+S"@$QMVU6.'S\5Y$HF&!LW'X^?.&U/<2&B^/8CO6ZA 106%LJ,&?.D=IUF
M]J0:1E?3ENWDDT]7JT&7%^2*Y^[=NS)EZFPSYF!\N_/;WK:U1*! ]+N\)\Y@
MVXX]=H[KZ_S#<0W4B!PV:KPMFZD(Q.'X?.,626W35?.K\=VXE;1HV5$.J*$.
M$NLI+BZ2W+Q<>9*;9_,?RSBP9,IY3J3H];I,9LY>Z)[2J[&;UBE=5J_^3*YG
M9IJW!0QXC,O-6W=,%(%(U*"QFZ,0JSJD8=>:3*LK7+=+^,R==X@F+5MUM&,P
MWV P8ZG(&37.?5L3*2PLD&W;=DK[]FZG$A/D-&W5SX#6$*HK:J(K=C:Y?^^^
M/>V_>.FR=.\UP.8ZCL62D!T[=NMW#RW@(?*%TST]%I_G^^"X2%IV)(+E3GGR
M1!/B*6 9DXUC:B>[;C"7(09[H:&\_OAV@OT'#MLXHD^XON$-TW? Q[;THKQC
M 78LP?(:Q$ZH#P%2^X-SL"OPOH#0$ V./7GJG-NZ6/.@WQWTWXE3I\[8=Q6!
M6!X#]'Q 3,*_#Q!$X2T3C(+E(8000@AY'MZ\I1.:(C?/2<GP?[0X#6&A <LH
MW/*);TMDW0B[P;+;H=#-G ?&+Y[>0#@X>.NI_-8,;&MY3;XR)F'IA.TXD2'=
M=S\HS5\9+U]H\*\E%FBLKMXLF^$9&&8-F[2VIX,([)>(&PMW@[]=C1D80;BY
MQ_IO&+BX\>[8N;?=5">3BCT:W$WORPXT6!7)%AHP!UQR)PL1ZS>J$=B^8W<U
MVMQ3[M@8..,,KW@*C77D,+JP]AJ&!ERB\1317+[U,Q@A&$><.[R'<0&W[G"[
M?4*^&@D-\Q:;*[6U*2@#1G5JNVYRXH2/^_%R@-"0DMI%ZXL7SMX$H0%&;VJ[
M+F8XVGG2-L&S .?8XWY?D/"9.^]/GN3IO)IDY\W%NF@O6[<'QK#]EKA\P/\^
M8<E23S4:$7<!PA'J&C5ZHNTL$0;Y[?<M2)YMVW:;RSO:"H%@T."1I:[TE7'^
MP@5IW;:K"1LP*'OT'&CGHTZ]5N;U<#GC6I"S+/!<6+AHA;6U<3,OCK26+8'A
M#WP[K=W!=?%(#7MX3,"-'W7"F(7( ./6$^Y;(EC.X[RZ8 "W-(\$[,8 7%UN
MEXA$'N7D2.^^']M<AT"! (C89C09X+<"2YMPC2-5*30$8X%SU*?_QW;.,,<P
M%NDZ#ZX'6PP#UZ=@#$N*]-7-/\Q#>#:@/QA["$40N2 $A5FU>KU\\%&34L\W
MQ _Q.\F$V^;KT'?V][%C)[4?:?;[B#@DF/N$$/*VDIE;+(?O%,JQ>X7Z6B!9
M>67M OS[?/F1RW?R?I'D%KG?:_RT7GA8)$?NNN,K2\AS7O/>>Q:1$_>*Y*C^
MC?*N/\%#SWB>%9?(::W'YWF0'[L_\>05E5@Y^/Z<EEL4_/OCP=_[;Q7(O'.Y
M,N=<GFR\_JS<NJK#[:<1.:+U'"VG7TAG'KA^503ZC>/+.S:<,$9GM2RT'6-[
MZ9'KG_\\DM#',/@.YZA:YZ*",0,1_<C:&Y2#.9&M<Z0Z8 PV7'LF,\_DRI(+
M>;+[9KX\*2Q[[D">SJ&3]W5,J]%>C,&-:K;A=?-F"@U/'TAD>E.+TY H-$32
MOR<1_3PZ)U4BSW(LOR-^<CBA 9]%9?'Y7/FY"1G.HP'"0H+0\).:YIW!4@2]
M*(*;NXIXV4*#.] =C,CP+5(Z)ABN:KSK3>2L.0OCMM@+@S:.&S_-7*+=,>Z)
M./Z>-G->D"MY5"XTM)85GZP)<KX>DBTT8%KY&_="O9''#AY-M*]X&A@VXI'P
ME!O+)6S-=--4,VCAV@V7YGX#AYOK,M* 02/5$!EF!A)VZ>C2K9];HZ_&(>9
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M]OS>G"QIO^.A_#0\'[0]OS$K2\X]P%;((O^H1JD=JT;JFHS8/:$3!%Q?3&R
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ML%J&@6]+YHTLZ=REKP6E:ZQSQ>(%:%FV)9[.I\\W;K%\J/]YITJXWS#*L43
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MO39]YCS]37/Q-\+S5(\(DL.7B7@74Z8BCH3[+8.W#I96>,JKFQ!"OJQ4)#0
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M6\L4OOFJ"MRLO1ZAP16X_K--9L3B1M6Y[#N#-&R\(<&8P'KR:WH#"OP-Z?.
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MTO.[(:$!2R<TP:NAQ[<D\FE_B43=1-]Y\YG\*M8=C8;(@!02&<R-Y:ITWXU
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MDQ]G).V#CC>.P=-@++V ,8AX(!G!$V?TV_<=A-]CN1"VRL380:3"/, R ?.
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MI$[]YJ7B!(0&K#.?,G6V%!866CYW#)^D$E(>[OIPK\$G<O;L>9DV?9YTZS%
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MA!!""$D:%!H((8000@@AA!"2-"@T$$(((8000@@A)$F(_'_SSK^KD^; &0
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  06,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MYRIAD GENETICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0494517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">322 North 2200 West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-3600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12gTitle', window );">Title of 12(g) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MYGN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12gTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(g) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection g<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12gTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !&!IEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( !&!IEJ/_N>&[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  1@:9:JL0B%C,!   B @
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( !&!IEIED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  1@:9:)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  1@:9:99!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mygn-20250506.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://myriad.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="mygn-20250506.htm">mygn-20250506.htm</File>
    <File>mygn-20250506.xsd</File>
    <File>mygn-20250506_def.xml</File>
    <File>mygn-20250506_lab.xml</File>
    <File>mygn-20250506_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mygn-20250506.htm": {
   "nsprefix": "mygn",
   "nsuri": "http://myriad.com/20250506",
   "dts": {
    "inline": {
     "local": [
      "mygn-20250506.htm"
     ]
    },
    "schema": {
     "local": [
      "mygn-20250506.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mygn-20250506_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mygn-20250506_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mygn-20250506_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 27,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://myriad.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mygn-20250506.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mygn-20250506.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(g) Security",
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://myriad.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000899923-25-000045-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000899923-25-000045-xbrl.zip
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MB)N-)$9TRDS?B*]-=G0Z)PK.X".02*2LP@D>@RSP?0YO$6!:,^6(=CT7$/=
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M.9.O<5'X5 ]-D66A2# J&ME#!MIMEN,[JZ>X_B5_83:AL$8Z8DIY%<0+ Q&
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M^+^N: 7R: '+3MCQ_/A\WJ1RYV$G<5J/FB?RV9/S1#[(6I!DF(BJE$&!L3"
MX,C;D.]_"SJHPZTMCM5\@I7*2TF-A:K%T: YBU6QSS4#H_(4#'IF+-138XC@
M8#>:>Q]@U.D9W=[6KRU8&X,MYC<UC$9]M[%0)Q@VA8O=;C#8E@[,+0:Q9+A5
MSW=:,]]I/3_>Q=N<5V3I>4J[4(>>I[0O,&XQ3ZE3CEY%ZT%P*1U+:!M*K]MG
MJ944M0%1EF8LSW>XV.9@[-RV<?\KS$R[A6\[F(X[*_*]D<6$127?+)@J=S^?
M=1LN5%^>9LMH%+Y+HJ;'\M!C-W.?J$.W@#R@6K7LLN0X_!Q@8\S[29T6'Y=8
MRZ?<UN0<G4_^8@.7 &N;T+5$A6"!.$)^00=A\WSZSZI_'M63\Z:QQH$UH(*I
MS* S\\V:7*"3R]L=[JS"J):ZT=2S=33"#L7;7VAV'#UN\KSM\0&8.198886F
M*R0;+SS';E2!8Y>EPW=V!I _8T,C+"<-V?-]G/-\YPG,G#P0<UH4_JGJ-.?9
MBH47A,TJ"$*M"6O3I7H(JU[$9"G:5^YPR=91ZTKXKK>'1I'XA]EL[SKY-$M2
M0YZC,)K,JT#F/:.=4S(O<\[,5E*T)#DSV0:)+@^,*;PFVNF_< +5<U#9X7R=
M'BH_;I-E>*39M>4CN>Q,O7(DM[XE33-K1YKTK6;CZ7N+U[6DM^4T[)5!R4_!
M9,W^HIK+_&[Q*XN*:+%N%]LLRBZ1Z?0*:XSS#N*RWJ0?K:RQ3B5EK,O",';)
MNR\>E31*3R576-\MYSRH<G@LV4ZFM0:S\\%\AD$4SIVWB0B\E<:(;#)UO!EC
MV0CD *&&,E#?ZC#WC-27*3'LB*7DV^U?Q4\\K!+$MI](F7-&%E>.)[W8 UDD
M-/%DD1#;5+0I_Z3TC.CO+8.L"6JL%[7]EXC:4A<7'6;W+U%)\HH'79%7(&3I
MBCQ=D7=*,.J*O,B[^&?2,N9#)/@+[V/4=7E5B#*7AW!?G(B8<TQ5J *JT]05
M>9H><[-3L]/>-:);Q*!MRO$2O>(<[W_;D0W'<H$179.7!XE[F,!UX4.%9SVC
MM^(9U4FM.46663=:)\&6+NW(2VG'RZL<\RXO==5CSFBT:D5T9WUC-59=(&.N
M6L@R3:-S$FQI4V=-F@QUY&0$',(X#?@D,G0*S[]UL5Z16$+3J&N;IBC(,K,(
MVP(7Z16 ?=_!:\5\N AW@55*)EE\IU2K"@R\+#J=')C46#?X42OBN44:,/*^
MUL/SP<C_8"-0Q 4+@FA^3^'Y=[L*_+LL.MUN_%LKXB=%6CUSO;M6Q@^:[%2Z
MCD>=*O#P$JESIW&K:MU[)V1EB L76/<^/:A+F$7]\KSD\J<%9@-%D7B'V:IG
M;N&?"1HG5N(U=5>:NIO]7>V:PU+W ?I/5*6^;U-GDOT")NL']ULY#Y\][/DY
M<6N/G.PO/WT]\M2V(2?(.5C'D)SL[U#M0F1S!IL#00>>?]#N,CD!Y,N;>^2=
M4(1D4 X-%.K]5)Y5*DIOD(_;-O"H$00&TA2\R0<&"#R+T(C+Q00Y"+ECGWNA
M_(,7^L1EC\2A(!DI4!8'2H.=WE)XX ]ZS\@5$&V-? OH6%+@+3PXALNNA(K%
MA>75R!4 =NCY+J<U\CCFP"LG%!DG[ )8*WX#N3"N9_D[P=@3C#B>)4^"(O(
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ML!,/X!Y.X9+#X4OV7+= 7@]</HAU HHG$Y#G GP"J18AJU=J!KP'U1Q[G>[
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MLZ:Q6IVKPV@Y199IK/82*&-"V^E!7;)Z@><0I6W[,O==QTS8[*I@/MQ9>J"
M)NPG"+N;12+J:0(YO+/HTP1V,6?SW1*Q[),&L$]4HM$1X C,BCH[KB]3$+6H
MRSQ&-I.&VCQ@$T%$:(UEYU[@+0Y&/[&?2:HS?*;^3B4DI1</)<CW_C9G1<_;
M\04QN4TIR!G5T >[*2MW3]0[+^Y"-H5E>+9(MVPZ>*K=*5]>0I(O^82!3=Q3
M,%@O]NR3G:C8=V:%>!"0H@4VZ'9P?HL[8GLB^1(2SHLG#A2J3=[637&3?FU
M(EOWL5M2OUL-HXM>ZU67=M+9Z\?%2$+4%ZP^?X0.8(5AL/F1E8X@![:1S.>
M+ANMF=TEH*7_._#L&?PS#B;.N_\/4$L#!!0    ( !&!IEH\!Y9>I1   -R
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MT,BWK5SCJZ+]APOYWG5<QS!1^!\^3%R-=!+,]+BV7=Z?G=\LR95/H<*HSE
M8OF0AH1-F#=2_!Z#/2!XF#PB>8"8(,CKHSHO'L'?C+;GH;D/DB@6LF$_CAB)
MM$H\)@!S.$+]0, -I$ &/JN3_.;$@41^#D\ND8,#Y&#9#XGA: N:^Q*#/KK&
ME2Y;JG8QURA57:-8MJR-B6U/=^8R5H0.AR&H-E!>>\\JGT#@@)6<!$&%EC]P
M21,& D(*2)+N\HE$"45"*K/$T.&$0E>3U,M[MDF&M\^\.YUU!#(2,0@P]&=Z
M\83T6!B/<4NP$3>.5(U?2<!#9'0N@>L5 Q3[F&R5?# *%8U8/)+AE$BPLV0P
MU4^F#\0]V"":ND6Z82$"/H)Q@ RB:=86Q"%,CL^A-N)HB<OZ>TSYV6+*KEEQ
M*SN)N=:*IE4J/E/,-63!(QP\CZ>Q85QH<V7TF^ *^ 4]RU&4.B+RL076B^.P
M1X'X%;#@3&&Y2':UBNN>[#;,MG?X3+$$8"RBB0P7ZCHZ(V GURFE0N-!O026
M2>3M"FE^ZA"G:)G0<86KMS/B>P;/_9M2:&>>^[X#]$/*B6X,MAS0<G1[ 8H8
MM'&XJ9 H_2A"8HXB,DAQ]%A"V"X%'V)!2"Q54LU$A M*2?=\EQ)O%* ?4DI<
M"X:6!+Z@H MFT1 75T& 3NYFTJ+\HT@+0)7A+>#JF[:%[?J&D^\=;28[DK[O
MTN.- O0N/2+5EG+$Q'?(D,J[#%DG0XK,<//>9C(D[?O64E*O$Z]:\/62 !(3
MS%_:@%GAOQ;B:4 )D/X>/WJ^^%&Q;%K%[<K_UMUW@"%J.PE%V36S5G+V;%$:
M4R];D_B:N?@;?'DY>=G#ZQ,OI%(>6KG!8191W B*B]7E$]WIH!>'>?DLQ2_O
M6[=KJ"[35PPTR[',[ "-..YSN#-7F]M8PJGF0;T$"" R#KE/,E#VH>*ILNM
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MR,)!#<?D8BHX]<EG%C&PA.0Q:4>>2?*YY'X.60^YY1\_5QW'.DE%H+ZR3XX
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M".E/A[#1L%""7T7228O%I W^'0DR9CW)%X\Y'%*!.1#,*-J5DZQ=F@2G>F(
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M""4:(>N/WDCKVY8 C1^__W:,9>F8+\:C[_52>[-\*!X?--M!6&UZ-+ZWM&Q
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MLZ,)]#"U;7'V&.TNS*_%/!-9E>6SWTVJ+C,^GR:::A$C";@*S2P60PU2&#(
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M96QE87-E+FAT;5!+ 0(4 Q0    ( !&!IEH\!Y9>I1   -R    1
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M4$L! A0#%     @ $8&F6JG1LRY]!P  I#H  !4              ( !KW0
L &UY9VXM,C R-3 U,#9?<')E+GAM;%!+!08     !@ & ),!  !??      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>mygn-20250506_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mygn-20250506.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2025-05-06</startDate>
            <endDate>2025-05-06</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0000899923</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-06</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-05-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-4">MYRIAD GENETICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">0-26642</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">87-0494517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">322 North 2200 West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">84116</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">584-3600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12gTitle contextRef="c-1" id="f-18">Common Stock, $0.01 par value</dei:Security12gTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">MYGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
